DNDNQ, was high as $54 a few years back. Its 'Provenge' is the only FDA approved drug in the sector (already sold for $300 M in 2014 and increasing). Lots of big pharm. companies are going to bid it in Feb. Very possible for the Commons to get $3-$4.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.